Larimar Therapeutics (LRMR) Net Equity Issued and Repurchased (2013 - 2026)
Larimar Therapeutics (LRMR) recorded Net Equity Issued and Repurchased of -$201,000 in Q4 2025.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
For FY2025, Larimar Therapeutics reported Net Equity Issued and Repurchased of $65.09 million, down 59.8% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $161.81 million in FY2024, $75.26 million in FY2022 (+278.5%) and $19.89 million in FY2021 (-73.7%).
- The Q4 2025 figure is the highest quarterly Net Equity Issued and Repurchased since Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Larimar Therapeutics | 279.45 Mn | -389.49 Mn | - | -435,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -435,000.00 |
| Mar 31, 2026 | 108.12 Mn |
| Dec 31, 2025 | -201,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | -334,000.00 |
| Mar 31, 2024 | 162.15 Mn |
| Dec 31, 2022 | -316,000.00 |
| Sep 30, 2021 | 19.69 Mn |
| Dec 31, 2020 | 242,000.00 |
| Sep 30, 2020 | -135,000.00 |
| Jun 30, 2020 | 75.48 Mn |
| Mar 31, 2020 | 10,000.00 |
| Dec 31, 2019 | 59,000.00 |
| Sep 30, 2019 | 40,000.00 |
| Mar 31, 2019 | 95,000.00 |
| Dec 31, 2018 | 2.07 Mn |
| Sep 30, 2018 | 64.80 Mn |
| Jun 30, 2018 | 86,000.00 |
| Mar 31, 2018 | 261,000.00 |
API Access
Larimar Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();